Imexpharm

Imexpharm Dividend Growth

Year-over-Year Dividend Growth of Imexpharm (IMP.VN) as of Oct 27, 2026.

Dividend Growth

0.00

Last updated:

Year-over-Year Dividend Growth of Imexpharm is 2025 0.00 . Year-over-Year Dividend Growth of Imexpharm was 2024 10.00 % . It decreases by % lower compared to the previous year.

The Imexpharm Dividend Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Growth
Date
Dividend Growth
Jan 1, 2016
11.11 VND
Jan 1, 2017
-25.00 VND
Jan 1, 2020
-34.00 VND
Jan 1, 2021
50.00 VND
Jan 1, 2022
0.00 VND
Jan 1, 2023
-30.00 VND
Jan 1, 2024
10.00 VND
Jan 1, 2025
0.00 VND
The Imexpharm Dividend Growth history
YEARDividend GrowthYoY
0.00-100.00%
10.00 %-133.33%
-30.00 %—
0.00-100.00%
50.00 %-247.06%
-34.00 %+35.99%
-25.00 %-325.02%
11.11 %-86.11%
80.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

On Eulerpool you can find the complete historical development of Year-over-Year Dividend Growth Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Dividend growth measures the percentage increase in dividends compared to the previous year. Consistent dividend growth signals financial strength and shareholder commitment.

To evaluate Year-over-Year Dividend Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Dividend Growth.

Year-over-Year Dividend Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Dividend Growth's Imexpharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Imexpharm

All Key Metrics — Imexpharm